Skip to main content
Novacyt logo

Novacyt — Investor Relations & Filings

Ticker · ALNOV ISIN · FR0010397232 LEI · 213800BWAC2BF295EG28 PA Manufacturing
Open in API
Filings indexed 1,101 across all filing types
Latest filing 2023-12-21 Regulatory Filings
Country FR France
Listing PA ALNOV

About Novacyt

https://novacyt.com/

Novacyt is an international molecular diagnostics company that provides a broad portfolio of integrated technologies and services. The company's core activities include the design, development, manufacturing, and commercialization of in vitro and molecular diagnostic tests, with a specialization in real-time PCR (qPCR) kits and reagents. Novacyt's solutions are applied across various markets, including clinical diagnostics for human health, with a focus on infectious diseases and oncology, as well as animal health and food safety. The company also offers custom development services, contract manufacturing, and pharmaceutical research services such as whole genome sequencing.

Recent filings

Filing Released Lang Actions
Update on Taiwan laboratory disposal
Regulatory Filings Classification · 100% confidence The document is identified by the presence of the 'RNS Number' header and the concluding boilerplate text referencing 'RNS, the news service of the London Stock Exchange' and the 'Financial Conduct Authority'. The content itself is a brief announcement providing an 'Update on Taiwan laboratory disposal' and states that a further update will be provided in January 2024. This structure—a short, timely announcement distributed via an official regulatory news service (RNS) that does not contain the full financial report itself—best fits the Regulatory Filings (RNS) category, which serves as the general category for miscellaneous regulatory announcements not covered by more specific codes like 10-K or ER. Given the document length is just over 5,000 characters and it is a direct update/announcement, RNS is the most appropriate classification.
2023-12-21 English
Liquidity Agreement and Total Voting Rights
Transaction in Own Shares Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states it is providing a 'Liquidity Agreement Monthly Update and Total Voting Rights'. It details share purchases and sales under a liquidity agreement for the period of November 1 to November 30, 2023, and provides the 'Total Voting Rights' figure (70,626,248 shares). This content relates to share capital management and disclosure of total shares outstanding, which is a mandatory regulatory disclosure, often associated with major shareholding notifications or general regulatory updates. Since it is a specific, recurring update on share activity and total rights, and it is distributed via RNS, it fits best under the general 'Regulatory Filings' category (RNS) as it is not a specific report like 10-K, IR, or a dividend announcement (DIV). It is not a Director's Dealing (DIRS) as it concerns the company's own treasury shares under an agreement, not executive trades. It is also not a Major Shareholding Notification (MRQ) which typically reports changes by external shareholders crossing thresholds. Given the nature of the RNS distribution and the content being a routine update on treasury stock management and total voting rights, RNS is the most appropriate general regulatory classification.
2023-12-01 English
IVDR certification for DPYD genotyping assay
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 5611S' and is dated '07 November 2023'. It contains a headline announcing a specific operational achievement ('IVDR certification achieved for DPYD genotyping assay') and includes contact details typical of a regulatory news service release. The presence of the RNS header and the nature of the announcement (a specific, non-periodic operational update) strongly suggest this is a general regulatory announcement. Since it is not a full financial report (10-K, IR), an earnings release (ER), or a specific management/governance filing, the most appropriate classification is the general regulatory announcement category, RNS.
2023-11-07 English
Certification IVDR obtenue pour le test de génotypage DPYD
Regulatory Filings Classification · 100% confidence The document is a press release from Novacyt S.A. announcing that its DPYD genotyping test has obtained IVDR certification (a regulatory compliance achievement for an in vitro diagnostic medical device in the EU). The text details the significance of the certification, quotes the CEO, and provides company background. This type of announcement, focusing on a specific regulatory milestone or product update that is not a full financial report (like 10-K or IR) or a general regulatory filing (RNS), fits best under the category of a general announcement or update. Since it is not a management change (MANG), director dealing (DIRS), dividend (DIV), or capital change (CAP), and it is not a transcript (CT) or a formal financial report (ER, IR, 10-K), it is most appropriately classified as a general Regulatory Filing (RNS) as a catch-all for significant, non-standard announcements, or potentially a Legal/Regulatory update if the IVDR compliance itself is viewed as a regulatory event. Given the context of a product achieving regulatory compliance, RNS (Regulatory Filings) is the most suitable general category for this type of corporate news release that doesn't fit the highly specific financial or governance codes. It is not an announcement of a report being published (RPA), but the report/certification itself.
2023-11-07 French
Liquidity Agreement and Total Voting Rights
Transaction in Own Shares Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange.' The content details a 'Liquidity Agreement Monthly Update' concerning share purchases/sales under that agreement and provides the 'Total Voting Rights' as of October 31, 2023. This type of routine, periodic update regarding share structure, treasury shares, and voting rights, disseminated via the RNS system, fits best under the general 'Regulatory Filings' category, as it is not a primary financial report (like 10-K or IR), a specific management change (MANG), or a dividend notice (DIV). While it contains voting rights information, it is not the official result of a vote (DVA), but rather a statutory disclosure related to share capital.
2023-11-01 English
Result of AGM
AGM Information Classification · 99% confidence The document explicitly states it is announcing the 'Result of AGM' (Annual General Meeting). It mentions that 'all resolutions proposed at the ordinary general meeting part of the Company's Annual General Meeting (AGM), held today, were duly passed.' This directly corresponds to the definition of AGM Information (AGM-R). Although it is a short announcement (under 5099 characters) about the meeting results, the core subject matter is the AGM outcome, making AGM-R more specific than a general RPA or RNS.
2023-10-26 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.